Budget Amount *help |
¥21,710,000 (Direct Cost: ¥16,700,000、Indirect Cost: ¥5,010,000)
Fiscal Year 2018: ¥5,070,000 (Direct Cost: ¥3,900,000、Indirect Cost: ¥1,170,000)
Fiscal Year 2017: ¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000)
Fiscal Year 2016: ¥6,760,000 (Direct Cost: ¥5,200,000、Indirect Cost: ¥1,560,000)
Fiscal Year 2015: ¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000)
|
Outline of Final Research Achievements |
In this study, we aimed to search for novel causative genes of pulmonary arterial hypertension (PAH) and to elucidate the roles of long non-coding RNA in PAH by collecting large samples from Japanese PAH patients. SOX17 and RNF213 were identified as novel causative genes of PAH by whole exome sequencing. Furthermore, we succeeded in narrowing down long non-coding RNAs (lncRNAs), which are thought to have the important epigenetic roles for the pathogenesis of PAH through multidisciplinary analysis including lncRNA array.
|